Moreover, complement modulation by using C3aR and C5aR antagonists and an anti-C5 blocking antibody was found to be effective in animal studies by ameliorating arthritis or even preventing the disease (35–37). This evidence concerns the gene C3AR1 and arthritic joint disease.